
Johnson & Johnson Development Corporation

Artiva Biotherapeutics Establishes U S Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply
Elevation Oncology Announces Pricing of Initial Public Offering
RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
2 images — click to enlarge
No questions yet. Be the first to ask about venBio.
Similar listings buyers compare against this one.

Johnson & Johnson Development Corporation

Panakes Partners

Coparion

Companion Fund

Greencoat Capital

Raba
Everything here links back to the same verified catalogue. Pick your next stop.